Rollins (ROL) Q1 2026 earnings review
Top-Line Re-Accelerates Late, But Margins Take a Hit
Rollins delivered a mixed start to 2026. While total revenue grew a healthy 10.2% to $906M, organic growth continued its year-long decelerating trend, landing at 6.6%. However, management noted a sharp inflection in March, exiting the quarter with over 8% organic growth as the peak season began. The bottom line tells a tougher story: despite management touting 'operational excellence,' Adjusted EBITDA margins compressed by 110 bps year-over-year. Rising insurance claims and deleverage on employee costs overshadowed the volume gains, marking a rare profitability step-back for the pest control giant.
🐂 Bull Case
While the 6.6% organic growth rate for the full quarter looks soft, exiting March at >8% organic growth shows demand is accelerating exactly when it matters—heading into the Q2/Q3 peak season.
The recently announced Romex acquisition proves the M&A pipeline remains highly active. Acquisitions added a reliable 3.6% to top-line growth in Q1.
🐻 Bear Case
Gross margin dropped 60 bps and Adjusted EBITDA margin fell 110 bps. If price increases cannot offset rising insurance and labor costs on lower early-season volumes, peak season profitability may disappoint.
Residential organic growth has been steadily decelerating for five quarters, dropping to a new low of 4.2% this quarter. The core consumer is clearly optimizing spending.
⚖️ Verdict: ⚪
Neutral. The late-quarter revenue acceleration is a strong positive, but the margin degradation is impossible to ignore. Rollins needs to prove the Q1 margin compression was purely an early-season volume issue, not a structural cost problem.
Key Themes
Data Contradicts 'Operational Excellence' Narrative
CEO Jerry Gahlhoff cited an 'ongoing focus of our teammates on operational excellence.' The data sharply contradicts this in the short term. Employee expenses deleveraged (rising from 31.8% to 32.0% of revenue), and insurance/claims spiked (2.0% to 2.3%). This cost creep drove a 120 bps decline in operating margin and an earnings profile that failed to scale with double-digit revenue growth.
Late-Quarter Acceleration Signals Macro Resilience
Despite ongoing investor fears regarding a tapped-out consumer, Rollins' business model proved its macro resilience. The company exited March with approximately 12% total growth and over 8% organic growth. This reversing momentum (accelerating out of a slow winter) suggests the consumer is still willing to pay for essential home protection as bug and pest activity increases.
Residential Segment Growth Decelerating
The Residential segment—Rollins' largest—is losing momentum. Organic growth decelerated to 4.2% in 26Q1, down from 5.7% a year ago and 4.4% in the prior quarter. While M&A is masking some of the weakness (total residential grew 9.3%), organic core traction is clearly slowing.
Termite & Ancillary Services Remain the Engine
While residential cools, the Termite & Ancillary segment remains a powerhouse, accelerating sequentially. Organic growth rebounded to 9.8% (up from 7.5% in 25Q4). This highlights the success of cross-selling high-ticket protective services to the existing customer base without requiring new lead generation.
Free Cash Flow Reversing on Timing Issues
Free Cash Flow dropped 20.6% YoY to $111.2M. While management attributed this to timing—a $40M hit from tax credit planning strategies and a $9M transition to semi-annual interest payments—it restricts near-term capital flexibility and requires monitoring to ensure these are truly one-off timing shifts.
M&A Playbook Continues with Romex
Rollins completed the Romex acquisition in April 26Q2, continuing its aggressive roll-up strategy. M&A added a reliable $29.8M (3.6%) to Q1 revenue. By plugging newly acquired brands into Rollins' centralized digital demand generation activities and proprietary platforms (like HomeSuite), the company consistently drives post-acquisition synergies.
Other KPIs
Accelerating. The commercial division bounced back nicely from a 6.4% organic growth rate in 25Q4 to 7.7% in 26Q1. This validates the heavy investments management made in B2B sales headcount throughout 2025.
Up 9.1% year-over-year. While net income growth was muted at 2.5%, the combination of share repurchases executed in late 2025 and add-backs for acquisition-related amortization allowed adjusted EPS to grow at a much healthier clip.
Decelerating profitability. This line item deleveraged by 60 basis points year-over-year (up from 48.6% in 25Q1). Increases in fleet expenses, insurance, and frontline employee costs outpaced pricing power in the quarter.
Guidance
Accelerating. Management explicitly highlighted the March exit rate to reassure investors that the 6.6% Q1 organic print was an early-quarter anomaly and that momentum is building into the critical spring and summer months.
Management anticipates 'improving profitability in our underlying operations as we enter peak season.' This implies a reversal of the 110 bps Q1 EBITDA margin contraction, heavily relying on volume leverage to absorb fixed investments.
Key Questions
Margin Contraction Path to Recovery
Adjusted EBITDA margins compressed by 110 basis points this quarter. How much of this is structural (insurance claims, wage inflation) versus purely deleveraging on lower early-season volumes?
Residential Organic Slowdown
Residential organic growth has decelerated for several quarters, hitting 4.2% in Q1. Is this driven by lower lead volumes, pushback on pricing, or changes in customer retention?
Romex Acquisition Impact
You highlighted the Romex acquisition in April. What is the expected annual revenue contribution and margin profile of this deal, and does it mirror the success you had with Saela last year?